eDelphi Methodology
Cross-source consensus on eDelphi Methodology from 1 sources and 7 claims.
1 sources · 7 claims
How it works
Benefits
Risks & contraindications
Highlighted claims
- Potential limitations of the eDelphi approach include attrition across rounds, limited global generalisability, and expert perspectives shaped by regional contexts. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study
- The Delphi method is suited to complex and emerging healthcare policy areas because it collects structured judgement from experts over multiple rounds, allows review of aggregated feedback, and preserves anonymity. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study
- Consensus will be defined as at least 70% of respondents selecting agree or strongly agree, or an interquartile range of 1 or less. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study
- Qualitative open-text responses will be coded and thematically analysed so that novel or minority perspectives are not lost in numerical aggregation. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study
- Persistently disputed criteria may be identified as areas for future inquiry rather than being forced into artificial consensus. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study
- Anonymity in the Delphi process can reduce social desirability bias and encourage candid input. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study
- Likert-scale ratings may oversimplify complex policy positions, though open-text prompts and thematic analysis are intended to capture nuance and minority views. — Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study